Genomic & Biopharma NewsMylan lowballed Medicaid on EpiPen by $1.27B, far more than its DOJ settlement: HHS
Mylan agreed to a $465 million settlement with the U.S. government last fall in a move to put some of its EpiPen problems in the past. But federal officials say taxpayers suffered $1.27 billion in harms—and that DOJ deal has yet to be finalized.
|Fierce Pharma, 2017-06-01 14:59:25|
Cancer costs are up—but there's more to the story than rising prices, report says
The cost of treating cancer has increased over the past few years—there’s no denying that. But there’s more to that increase than meets the eye. In other words? It's not just about prices.
|Fierce Pharma, 2017-06-01 14:58:20|
Researchers reveal how social laughter leads to endorphin release in the brain
Finnish and British researchers have revealed how laughter releases endorphins in the human brain. The more opioid receptors the participants had in their brain, the more they laughed during the experiment.
|News Medical Life Sciences, 2017-06-01 14:39:11|
New test could bridge a gap in HIV research
Researchers have long sought a cure for HIV, but its ability to hide itself in infected cells makes it difficult to determine if a patient is cured. University of Pittsburgh scientists have developed a new test that spots dormant, replicating HIV and is faster and cheaper than current tests.
|Fierce Biotech, 2017-06-01 14:32:42|
Autism alone not linked to convictions for violent crimes, study finds
A diagnosis of autism alone does not increase the risk of violent offending, suggests a study published in the June 2017 issue of the Journal of the American Academy of Child and Adolescent Psychiatry.
|News Medical Life Sciences, 2017-06-01 14:14:41|
Common acne medication can slow progress of relapsing-remitting MS, trial shows
A Canadian clinical trial led by researchers at the University of Calgary's Hotchkiss Brain Institute, at the Cumming School of Medicine, shows that minocycline, a common acne medication, can slow the progress of relapsing-remitting multiple sclerosis (MS) in people who have recently experienced their first symptoms.
|News Medical Life Sciences, 2017-06-01 14:01:00|
Orlando Health deploys NanoKnife as new weapon in battle against pancreatic cancer
Oncologists at UF Health Cancer Center Orlando Health are deploying NanoKnife as a new weapon in the battle against pancreatic cancer.
|News Medical Life Sciences, 2017-06-01 13:52:31|
Impaired ability to understand social cues may be linked to brain changes in people with MS
For people with multiple sclerosis (MS), an impaired ability to understand how others feel and think may be linked to subtle brain changes, according to a study published in the May 31, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology.
|News Medical Life Sciences, 2017-06-01 13:42:18|
$52M cash boost will help Deciphera push resistant tumor duo
Deciphera Pharmaceuticals will head to ASCO this week with a spring in its step after raising $52 million in a third-round financing.
|Fierce Biotech, 2017-06-01 13:38:55|